15 results were returned
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)
A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...
The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.
Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...